Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DCC-2036 (Rebastinib)

InhA, Func 1020172-07-9
Produktnummer ABIN4878278

Kurzübersicht für DCC-2036 (Rebastinib) (ABIN4878278)

Applikation

Inhibition Assay (InhA), Functional Studies (Func)
  • Verwendungszweck

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Produktmerkmale

    Target: Bcr-Abl inhibitor
    Receptor: Abl1,FLT3,KDR,Tie-2,Lyn,Src

    Aufreinigung

    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.

    Reinheit

    99.70 %

    Formel

    C30H28FN7O3

    Löslichkeit

    200 mM in DMSO
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Solid

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.

    Haltbarkeit

    24 months
  • Hintergrund

    Angiogenesis

    Molekulargewicht

    553.59 g/mol

    CAS-Nummer

    1020172-07-9
Sie sind hier:
Chat with us!